|
Volumn 18, Issue 9, 2010, Pages 646-650
|
[Programmed death-1 (PD-1) and PD-L1 expression during antiviral treatment of chronic hepatitis B].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIVIRUS AGENT;
CD274 PROTEIN, HUMAN;
HEPATITIS B(E) ANTIGEN;
NUCLEOSIDE;
PDCD1 PROTEIN, HUMAN;
PROGRAMMED DEATH 1 LIGAND 1;
PROGRAMMED DEATH 1 RECEPTOR;
PYRIMIDINONE DERIVATIVE;
TELBIVUDINE;
ADULT;
ARTICLE;
BLOOD;
CD8+ T LYMPHOCYTE;
FEMALE;
GENETICS;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
IMMUNOLOGY;
MALE;
METABOLISM;
ADULT;
ANTIGENS, CD274;
ANTIVIRAL AGENTS;
CD8-POSITIVE T-LYMPHOCYTES;
FEMALE;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
MALE;
NUCLEOSIDES;
PROGRAMMED CELL DEATH 1 RECEPTOR;
PYRIMIDINONES;
YOUNG ADULT;
|
EID: 79961151793
PISSN: 10073418
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|